Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07113041 · ClinicalTrials.gov registry record · NA

Neuromodulation-Enhanced Use of RObotic BALANCE Training to Improve Balance Function in Individuals With Stroke

A NA study of Stroke and Stroke, Ischemic, sponsored by Kessler Foundation.

Recruiting
Registry status
NA
Development phase
45
Enrollment target
1
Study location

NCT07113041: Recruiting NA study of Stroke and Stroke, Ischemic, sponsored by Kessler Foundation.

NCT07113041 is a NA study of Stroke and Stroke, Ischemic that is actively recruiting participants, run by Kessler Foundation. The registered enrollment target is 45 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07113041, a NA study of Stroke and Stroke, Ischemic, is actively recruiting participants, sponsored by Kessler Foundation.

RECRUITING
Registry status
NA
Development phase
45 participants
Enrollment target
1
Study location

Study Summary

Our proposed study, "NEUROBALANCE Stroke,"; aims to evaluate the effectiveness of a combined intervention involving robotic balance training and noninvasive brain stimulation in improving balance function and postural control in individuals with chronic stroke. The study will recruit 45 participants who have had a stroke at least 6 months before enrolment and experience persistent balance and gait deficits. Participants will be randomized into three groups: (1) robotic balance training with active brain stimulation, (2) robotic balance training with sham brain stimulation, and (3) standard-of-care rehabilitation. The study will involve 15 training sessions over 5 weeks, with assessments conducted at baseline, post-training, and two months post-training to evaluate balance recovery and retention. The primary focus is understanding how this intervention affects brain and muscle activity during balance tasks and how these changes translate into functional improvements in clinical outcome measures of balance function. Additionally, participant feedback on brain stimulation and exercise engagement will be collected to inform future studies. The findings may guide the development of personalized training protocols and contribute to broader rehabilitation strategies.

Primary Outcome

A widely used outcome measure of static standing balance function (Newstead et al., 2005), categorized under the 'Activity' subsection of ICF domain. BBS scores range from 0 to 56 (the higher, the better). The change in BBS scores from baseline to 4 weeks post-training will be the primary endpoint.

Interventions

  • DEVICE Combined (Robotic balance training and high-definition transcranial direct current stimulation)
  • OTHER Standard of Care Balance Training

Study Locations (1)

New Jersey

  • Kessler Foundation - West Orange

Trial Details

FieldValue
Enrollment Target 45 participants
Start Date 2025-06-01
Est. Completion 2029-08-31
Phase NA
Kessler Foundation

104 total trials

What NCT07113041 shows while recruiting

NCT07113041 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 45 participants, a relatively small participant target, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower).

The record links to 5 conditions, with Stroke appearing as the primary indexed condition, and to 2 interventions - of which Combined (Robotic balance training and high-definition transcranial direct current stimulation) is the first listed.

NCT07113041 reports a single indexed study location in New Jersey.

Frequently Asked Questions

What is clinical trial NCT07113041 about?

NCT07113041 is a clinical study titled "Neuromodulation-Enhanced Use of RObotic BALANCE Training to Improve Balance Function in Individuals With Stroke". Our proposed study, "NEUROBALANCE Stroke,"; aims to evaluate the effectiveness of a combined intervention involving robotic balance training and noninvasive brain stimulation in improving balance function and postural control in individuals with chronic stroke. The study will recruit 45 participants...

What is the current status of trial NCT07113041?

This trial is currently recruiting. It is a NA study. The enrollment target is 45 participants. The study started on 2025-06-01. Estimated completion is 2029-08-31.

What conditions does trial NCT07113041 study?

This clinical trial studies the following conditions: Stroke, Stroke, Ischemic, Balance Deficits, Stroke (CVA) or Transient Ischemic Attack, Stroke Gait Rehabilitation.

What interventions are being tested in trial NCT07113041?

The interventions under investigation include: Combined (Robotic balance training and high-definition transcranial direct current stimulation) (DEVICE), Standard of Care Balance Training (OTHER).

Who is sponsoring clinical trial NCT07113041?

This trial is sponsored by Kessler Foundation, which has 104 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07113041 being conducted?

This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07113041's enrollment target sits among peer trials

45 250th of 454 higher than 201 of 454 other Stroke trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00804154 · 45 participants · Phase 1

    Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer

  • NCT01851694 · 45 participants · NA

    Beta-cell Response to Incretin Hormones in Cystic Fibrosis

  • NCT02896335 · 45 participants · Phase 2

    Palbociclib and Pembrolizumab In Central Nervous System Metastases

  • NCT03454035 · 45 participants · Phase 1

    Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07113041, the US trial registry maintained by the National Library of Medicine. NCT07113041 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.